Schedule 2020

9:45 – 10:25 Welcome and badges distribution

Morning session

10:30 – 10:45 Introductory words of academic and industry liasons

Prof Eric Allemann – Professor Department of Pharmaceutical Technology (UniGe)

10:45 – 11:05 Targeting conserved pathways of aging and disease with nutraceuticals

Dr Vincenzo Sorrentino – Team Leader (Nestlé Institute of Health Sciences)

11:05 – 11:25 Bringing cancer immunotherapy to patients with innovative translational models

Dr Nikolche Gjorevski – Lab Head (Roche)

11:25 – 11:50 Controlled‐release systems for biologics

Dr Pierre Maudens – Principal Scientist (Novartis)

11:50 – 12:10 Nanofluidics drives protein quantification for point-of-care diagnostics

Ms Romy Benninga – Biology R&D Manager (Abionic)

12:10 – 13:30 Networking lunch break

Afternoon session

13:30 – 13:55 Between genes and patients – bringing organoids from research to industry – an EPFL startup story

Dr Sylke Hoehnel – CEO & Co-Founder (Sun Biosciences)

13:55 – 14:15 My journey in cell and gene therapy

Dr Floriane Groell – Senior Scientist (Novartis)

14:15 – 14:35 Angiopoietin 4: Player or Bystander in Retinal Vascular Disease

Dr Dragana Avramovic – Postdoctoral Researcher (Roche)

14:35 – 15:00 Trends in Clinical Development in 2020

Dr Vincent Grek- Global Clinical Development Lead (Nestlé Health Science)

15:00 – 15:30 Coffee break

15:30 – 15:50 Pre-clinical efficacy of an oral ferroportin inhibitor for the treatment of beta-thalassemia

Dr Naja Nyffenegger – Senior Scientist Biology (Vifor Pharma)

15:50 – 16:10 Career Transition from Academia to Modelling & Simulation at Novartis

Dr Justine Badée – Investigator (Novartis)

16:10 – 16:35 Leveraging advanced in vitro systems to support drug development

Dr Remi Villenave – Lab Head (Roche)

16:35 – 16:40 Closing Remarks

16:40 – 18:30 Apéro

%d bloggers like this: